60 related articles for article (PubMed ID: 21094053)
1. The perioperative granulocyte/lymphocyte ratio is a clinically relevant marker of surgical stress in patients with colorectal cancer.
Tabuchi T; Shimazaki J; Satani T; Nakachi T; Watanabe Y; Tabuchi T
Cytokine; 2011 Feb; 53(2):243-8. PubMed ID: 21094053
[TBL] [Abstract][Full Text] [Related]
2. In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression.
Shimazaki J; Goto Y; Nishida K; Tabuchi T; Motohashi G; Ubukata H; Tabuchi T
Oncology; 2013; 84(6):356-61. PubMed ID: 23689116
[TBL] [Abstract][Full Text] [Related]
3. [Selected hematopoietic cytokines in patients with colorectal cancer].
Mroczko B; Ławicki S; Szmitkowski M; Czygier M; Okulczyk B; Piotrowski Z
Pol Merkur Lekarski; 2003 Nov; 15(89):416-9. PubMed ID: 14969133
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients.
Mroczko B; Groblewska M; Wereszczynska-Siemiatkowska U; Kedra B; Konopko M; Szmitkowski M
Clin Chim Acta; 2006 Sep; 371(1-2):143-7. PubMed ID: 16603145
[TBL] [Abstract][Full Text] [Related]
5. Cytokine response to human liver ischemia-reperfusion injury during hepatectomy: marker of injury or surgical stress?
Hanazaki K; Monma T; Hiraguri M; Ohmoto Y; Kajikawa S; Matsushita A; Nimura Y; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2001; 48(37):188-92. PubMed ID: 11268962
[TBL] [Abstract][Full Text] [Related]
6. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
ławicki S; Czygier M; Gacuta-Szumarska E; Knapp P; Szmitkowski M
Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841
[TBL] [Abstract][Full Text] [Related]
7. Perioperative prophylaxis with granulocyte colony-stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved recovery: A randomized, controlled trial.
Bauhofer A; Plaul U; Torossian A; Koller M; Stinner B; Celik I; Sitter H; Greger B; Middeke M; Schein M; Wyatt J; Nyström PO; Hartung T; Rothmund M; Lorenz W
Surgery; 2007 Apr; 141(4):501-10. PubMed ID: 17383527
[TBL] [Abstract][Full Text] [Related]
8. [Plasma macrophage colony-stimulating factor, granulocyte macrophage colony-stimulating factor and granulocyte colony-stimulating factor levels in continuous ambulatory peritoneal dialysis patients].
Saionji K; Hamada T; Higurashi H; Shimizu T; Hukuromoto T; Takeshima S; Kurotani W
Rinsho Byori; 1997 May; 45(5):493-7. PubMed ID: 9170979
[TBL] [Abstract][Full Text] [Related]
9. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma.
Mels AK; Statius Muller MG; van Leeuwen PA; von Blomberg BM; Scheper RJ; Cuesta MA; Beelen RH; Meijer S
Br J Surg; 2001 Apr; 88(4):539-44. PubMed ID: 11298622
[TBL] [Abstract][Full Text] [Related]
10. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
[TBL] [Abstract][Full Text] [Related]
11. [CSF in laboratory medicine].
Im T; Yasui Y; Yamane T; Tatsumi N
Rinsho Byori; 1993 Apr; 41(4):366-71. PubMed ID: 7688830
[TBL] [Abstract][Full Text] [Related]
12. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
13. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
Kirman I; Belizon A; Balik E; Feingold D; Arnell T; Horst P; Kumara S; Cekic V; Jain S; Nasar A; Whelan RL
Eur J Surg Oncol; 2007 Dec; 33(10):1169-76. PubMed ID: 17512160
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
[TBL] [Abstract][Full Text] [Related]
15. Physiological neutrophilia is associated with elevated serum level of macrophage colony-stimulating factor (M-CSF).
Hatake K; Miura Y; Motoyoshi K
Am J Hematol; 1996 May; 52(1):66. PubMed ID: 8638622
[No Abstract] [Full Text] [Related]
16. Serum cytokine levels in patients with neutropenia.
Greendyke RM; Sharma K; Gifford FR
Arch Pathol Lab Med; 1994 Dec; 118(12):1193-5. PubMed ID: 7526820
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
18. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
19. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M
Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
[TBL] [Abstract][Full Text] [Related]
20. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
